{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T18:15:16Z","timestamp":1794334516345,"version":"4.9.0"},"reference-count":128,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T00:00:00Z","timestamp":1728950400000},"content-version":"vor","delay-in-days":288,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003093","name":"Malaysia Ministry of Higher Education","doi-asserted-by":"publisher","award":["FRGS\/1\/2022\/SKK12\/UMS\/01\/2"],"award-info":[{"award-number":["FRGS\/1\/2022\/SKK12\/UMS\/01\/2"]}],"id":[{"id":"10.13039\/501100003093","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Research in Microbial Sciences"],"published-print":{"date-parts":[[2024]]},"DOI":"10.1016\/j.crmicr.2024.100295","type":"journal-article","created":{"date-parts":[[2024,10,19]],"date-time":"2024-10-19T11:24:40Z","timestamp":1729337080000},"page":"100295","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Impacts of MDR\/XDR-TB on the global tuberculosis epidemic: Challenges and opportunities"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4362-1731","authenticated-orcid":false,"given":"Kai Ling","family":"Chin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Anibarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi Yuan","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Praneetha","family":"Palasuberniam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zainal Arifin","family":"Mustapha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria E.","family":"Sarmiento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armando","family":"Acosta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.crmicr.2024.100295_bib0001","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S1473-3099(22)00142-6","article-title":"World Tuberculosis Day 2022: Aligning COVID-19 and tuberculosis innovations to save lives and to end tuberculosis","volume":"22","author":"Ntoumi","year":"2022","journal-title":"Lancet Infect. Dis."},{"issue":"6","key":"10.1016\/j.crmicr.2024.100295_bib0002","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1093\/infdis\/jiy265","article-title":"Risk and timing of tuberculosis among close contacts of persons with infectious tuberculosis","volume":"218","author":"Reichler","year":"2018","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.crmicr.2024.100295_bib0003","series-title":"Global Tuberculosis Report 2023","year":"2023"},{"issue":"4","key":"10.1016\/j.crmicr.2024.100295_bib0004","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.idc.2019.09.002","article-title":"Multidrug and extensively drug-resistant tuberculosis: Epidemiology, clinical features, management and treatment","volume":"33","author":"Tiberi","year":"2019","journal-title":"Infect. Dis. Clin. North Am."},{"issue":"2","key":"10.1016\/j.crmicr.2024.100295_bib0005","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.cmi.2023.09.015","article-title":"Effectiveness and safety of tuberculosis preventive treatment for contacts of patients with multidrug-resistant tuberculosis: A systematic review and meta-analysis","volume":"30","author":"Zhou","year":"2024","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.crmicr.2024.100295_bib0006","series-title":"Companion Handbook to the WHO Guidelines for the Programmatic Management of Drug-Resistant Tuberculosis","year":"2014"},{"issue":"12","key":"10.1016\/j.crmicr.2024.100295_bib0007","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1007\/s10096-005-0042-6","article-title":"Usefulness of E-test strips for testing susceptibility of Mycobacterium tuberculosis complex strains","volume":"24","author":"Esteban","year":"2005","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.crmicr.2024.100295_bib0008","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.tube.2018.11.007","article-title":"Accuracy of the color plate micro-colony detection for the diagnosis of Mycobacterium tuberculosis complex in Northwest Ethiopia","volume":"114","author":"Shibabaw","year":"2019","journal-title":"Tuberculosis. (Edinb)"},{"issue":"3","key":"10.1016\/j.crmicr.2024.100295_bib0009","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1128\/JCM.42.3.1109-1114.2004","article-title":"Evaluation of the fully automated BACTEC MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to pyrazinamide, streptomycin, isoniazid, rifampin, and ethambutol and comparison with the radiometric BACTEC 460TB method","volume":"42","author":"Scarparo","year":"2004","journal-title":"J. Clin. Microbiol."},{"issue":"11","key":"10.1016\/j.crmicr.2024.100295_bib0010","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1046\/j.1469-0691.2003.00783.x","article-title":"Evaluation of the BacT\/ALERT 3D system for recovery and drug susceptibility testing of Mycobacterium tuberculosis","volume":"9","author":"Angeby","year":"2003","journal-title":"Clin. Microbiol. Infect."},{"issue":"2","key":"10.1016\/j.crmicr.2024.100295_bib0011","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1128\/JCM.06432-11","article-title":"Evaluation of the VersaTREK system compared to the Bactec MGIT 960 system for first-line drug susceptibility testing of Mycobacterium tuberculosis","volume":"50","author":"Espasa","year":"2012","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.crmicr.2024.100295_bib0012","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.mimet.2017.06.007","article-title":"Evaluation of the BACTEC MGIT 960 system and the resazurin microtiter assay for susceptibility testing of Mycobacterium tuberculosis to second-line drugs","volume":"139","author":"Gallo","year":"2017","journal-title":"J. Microbiol. Methods"},{"issue":"1","key":"10.1016\/j.crmicr.2024.100295_bib0013","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s10096-023-04693-8","article-title":"A descriptive study on isoniazid resistance-associated mutations, clustering and treatment outcomes of drug-resistant tuberculosis in a high burden country","volume":"43","author":"Pinhata","year":"2024","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"issue":"2","key":"10.1016\/j.crmicr.2024.100295_bib0014","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1128\/CMR.00059-10","article-title":"Laboratory diagnosis of tuberculosis in resource-poor countries: challenges and opportunities","volume":"24","author":"Parsons","year":"2011","journal-title":"Clin. Microbiol. Rev."},{"issue":"1","key":"10.1016\/j.crmicr.2024.100295_bib0015","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1128\/AAC.01209-13","article-title":"Sensititre MYCOTB MIC plate for testing Mycobacterium tuberculosis susceptibility to first- and second-line drugs","volume":"58","author":"Lee","year":"2014","journal-title":"Antimicrob. Agents Chemother"},{"issue":"4","key":"10.1016\/j.crmicr.2024.100295_bib0016","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1128\/AEM.70.4.2398-2403.2004","article-title":"Evaluation of a scanner-assisted colorimetric MIC method for susceptibility testing of gram-negative fermentative bacteria","volume":"70","author":"Rahman","year":"2004","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.crmicr.2024.100295_bib0017","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/978-1-4939-2450-9_17","article-title":"Microplate alamar blue assay (MABA) and low oxygen recovery assay (LORA) for Mycobacterium tuberculosis","volume":"1285","author":"Cho","year":"2015","journal-title":"Methods Mol. Biol."},{"issue":"1","key":"10.1016\/j.crmicr.2024.100295_bib0018","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1186\/s12866-014-0259-6","article-title":"Evaluation of the modified colorimetric resazurin microtiter plate-based antibacterial assay for rapid and reliable tuberculosis drug susceptibility testing","volume":"14","author":"Katawera","year":"2014","journal-title":"BMC. Microbiol."},{"issue":"12","key":"10.1016\/j.crmicr.2024.100295_bib0019","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0169188","article-title":"Evaluation of direct colorimetric MTT assay for rapid detection of rifampicin and isoniazid resistance in Mycobacterium tuberculosis","volume":"11","author":"Hundie","year":"2016","journal-title":"PLoS. One"},{"issue":"4","key":"10.1016\/j.crmicr.2024.100295_bib0020","article-title":"Epidemiological cut-off values for a 96-well broth microdilution plate for high-throughput research antibiotic susceptibility testing of","volume":"60","author":"Consortium","year":"2022","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.crmicr.2024.100295_bib0021","series-title":"Multidrug-resistant Tuberculosis (MDR-TB) - 2018 update","year":"2018"},{"key":"10.1016\/j.crmicr.2024.100295_bib0022","series-title":"WHO Consolidated Guidelines On tuberculosis: Module 3: Diagnosis \u2013 Rapid Diagnostics For Tuberculosis Detection","year":"2021"},{"key":"10.1016\/j.crmicr.2024.100295_bib0023","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.3389\/fmicb.2018.02224","article-title":"Optimized lysis-extraction method combined with IS6110-amplification for detection of Mycobacterium tuberculosis in paucibacillary sputum specimens","volume":"9","author":"Kolia-Diafouka","year":"2018","journal-title":"Front. Microbiol."},{"issue":"3","key":"10.1016\/j.crmicr.2024.100295_bib0024","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.02314-20","article-title":"Xpert MTB\/XDR: A 10-Color reflex assay suitable for point-of-care settings to detect isoniazid, fluoroquinolone, and second-line-injectable-drug resistance directly from Mycobacterium tuberculosis-positive sputum","volume":"59","author":"Cao","year":"2021","journal-title":"J. Clin. Microbiol."},{"issue":"7","key":"10.1016\/j.crmicr.2024.100295_bib0025","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1007\/s10096-020-03847-2","article-title":"Evaluation of the BD MAX\u2122 MDR-TB assay in a real-world setting for the diagnosis of pulmonary and extra-pulmonary TB","volume":"39","author":"Ciesielczuk","year":"2020","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"issue":"10","key":"10.1016\/j.crmicr.2024.100295_bib0026","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01582-19","article-title":"Advances in molecular diagnosis of tuberculosis","volume":"58","author":"MacLean","year":"2020","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.crmicr.2024.100295_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.mimet.2020.105960","article-title":"Clinical evaluation of an automated Real-Prep system for extracting nucleic acids to detect mycobacterial infection","volume":"174","author":"Kim","year":"2020","journal-title":"J. Microbiol. Methods"},{"issue":"7","key":"10.1016\/j.crmicr.2024.100295_bib0028","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0199869","article-title":"Automated TruTip nucleic acid extraction and purification from raw sputum","volume":"13","author":"Thakore","year":"2018","journal-title":"PLoS. One"},{"issue":"11","key":"10.1016\/j.crmicr.2024.100295_bib0029","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0225205","article-title":"Monitoring quality indicators for the Xpert MTB\/RIF molecular assay in Ethiopia","volume":"14","author":"Kebede","year":"2019","journal-title":"PLoS. One"},{"issue":"3","key":"10.1016\/j.crmicr.2024.100295_bib0030","first-page":"e02314","article-title":"Xpert MTB\/XDR: A ten-color reflex assay suitable for point of care settings to detect isoniazid-, fluoroquinolone-, and second line injectable drug-resistance directly from Mycobacterium tuberculosis positive sputum","volume":"59","author":"Cao","year":"2021","journal-title":"bioRxiv."},{"key":"10.1016\/j.crmicr.2024.100295_bib0031","doi-asserted-by":"crossref","first-page":"463","DOI":"10.2147\/IDR.S147272","article-title":"Evaluation of a new automated Abbott RealTime MTB RIF\/INH assay for qualitative detection of rifampicin\/isoniazid resistance in pulmonary and extra-pulmonary clinical samples of Mycobacterium tuberculosis","volume":"10","author":"Ruiz","year":"2017","journal-title":"Infect. Drug Resist."},{"issue":"4","key":"10.1016\/j.crmicr.2024.100295_bib0032","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.diagmicrobio.2017.08.016","article-title":"Laboratory evaluation of the Anyplex\u2122 II MTB\/MDR and MTB\/XDR tests based on multiplex real-time PCR and melting-temperature analysis to identify Mycobacterium tuberculosis and drug resistance","volume":"89","author":"Igarashi","year":"2017","journal-title":"Diagn. Microbiol. Infect. Dis."},{"issue":"4","key":"10.1016\/j.crmicr.2024.100295_bib0033","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1128\/JCM.02847-15","article-title":"Analytical and clinical evaluation of the epistem genedrive assay for detection of Mycobacterium tuberculosis","volume":"54","author":"Shenai","year":"2016","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.crmicr.2024.100295_bib0034","doi-asserted-by":"crossref","first-page":"25330","DOI":"10.1038\/srep25330","article-title":"Rapid diagnosis of MDR and XDR tuberculosis with the MeltPro TB assay in China","volume":"6","author":"Pang","year":"2016","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.crmicr.2024.100295_bib0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0150321","article-title":"GenoType mtbdrplus assay for rapid detection of multidrug resistance in Mycobacterium tuberculosis: A meta-analysis","volume":"11","author":"Bai","year":"2016","journal-title":"PLoS. One"},{"issue":"9","key":"10.1016\/j.crmicr.2024.100295_bib0036","article-title":"GenoType(\u00ae) MTBDRsl assay for resistance to second-line anti-tuberculosis drugs","volume":"9","author":"Theron","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"issue":"6","key":"10.1016\/j.crmicr.2024.100295_bib0037","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1128\/JCM.00251-16","article-title":"Multicenter noninferiority evaluation of Hain GenoType MTBDRplus Version 2 and Nipro NTM+MDRTB Line Probe Assays for detection of rifampin and isoniazid resistance","volume":"54","author":"Nathavitharana","year":"2016","journal-title":"J. Clin. Microbiol."},{"issue":"1","key":"10.1016\/j.crmicr.2024.100295_bib0038","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01871-17","article-title":"Detection of Mycobacterium tuberculosis pncA mutations by the Nipro Genoscholar PZA-TB II assay compared to conventional sequencing","volume":"62","author":"Willby","year":"2018","journal-title":"Antimicrob. Agents Chemother"},{"issue":"1","key":"10.1016\/j.crmicr.2024.100295_bib0039","doi-asserted-by":"crossref","first-page":"11760","DOI":"10.1038\/s41598-019-48289-9","article-title":"Fluoroquinolone heteroresistance in Mycobacterium tuberculosis: detection by genotypic and phenotypic assays in experimentally mixed populations","volume":"9","author":"Rigouts","year":"2019","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.crmicr.2024.100295_bib0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0228312","article-title":"A pilot study: VereMTB detection kit for rapid detection of multidrug-resistant mycobcterium tuberculosis in clinical sputum samples","volume":"15","author":"Ou","year":"2020","journal-title":"PLoS. One"},{"issue":"1","key":"10.1016\/j.crmicr.2024.100295_bib0041","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/s12879-018-3131-8","article-title":"GeneChip analysis of resistant Mycobacterium tuberculosis with previously treated tuberculosis in Changchun","volume":"18","author":"Zhang","year":"2018","journal-title":"BMC. Infect. Dis."},{"key":"10.1016\/j.crmicr.2024.100295_bib0042","doi-asserted-by":"crossref","first-page":"794","DOI":"10.3389\/fmicb.2019.00794","article-title":"Molecular diagnosis of drug-resistant tuberculosis; A literature review","volume":"10","author":"Nguyen","year":"2019","journal-title":"Front. Microbiol."},{"issue":"1","key":"10.1016\/j.crmicr.2024.100295_bib0043","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1054\/tuld.1998.0002","article-title":"Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update","volume":"79","author":"Ramaswamy","year":"1998","journal-title":"Int. J. Tuberc. Lung Dis."},{"issue":"3","key":"10.1016\/j.crmicr.2024.100295_bib0044","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0119628","article-title":"Genetic mutations associated with isoniazid resistance in Mycobacterium tuberculosis: A systematic review","volume":"10","author":"Seifert","year":"2015","journal-title":"PLoS. One"},{"key":"10.1016\/j.crmicr.2024.100295_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.tube.2020.101985","article-title":"Molecular analysis of streptomycin-resistance associating genes in Mycobacterium tuberculosis isolates from Nepal","volume":"125","author":"Shrestha","year":"2020","journal-title":"Tuberculosis. (Edinb)"},{"key":"10.1016\/j.crmicr.2024.100295_bib0046","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/951706","article-title":"Mutations found in embCAB, embR, and ubiA genes of ethambutol-sensitive and -resistant Mycobacterium tuberculosis clinical isolates from China","volume":"2015","author":"Xu","year":"2015","journal-title":"Biomed. Res. Int."},{"issue":"9","key":"10.1016\/j.crmicr.2024.100295_bib0047","doi-asserted-by":"crossref","first-page":"5267","DOI":"10.1128\/AAC.00204-15","article-title":"Systematic review of mutations in pyrazinamidase associated with pyrazinamide resistance in Mycobacterium tuberculosis clinical isolates","volume":"59","author":"Ramirez-Busby","year":"2015","journal-title":"Antimicrob. Agents Chemother"},{"issue":"4","key":"10.1016\/j.crmicr.2024.100295_bib0048","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1128\/AAC.06272-11","article-title":"Extending the definition of the gyrB quinolone resistance-determining region in Mycobacterium tuberculosis DNA gyrase for assessing fluoroquinolone resistance in M. tuberculosis","volume":"56","author":"Pantel","year":"2012","journal-title":"Antimicrob. Agents Chemother"},{"issue":"2","key":"10.1016\/j.crmicr.2024.100295_bib0049","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01299-16","article-title":"Molecular investigation of resistance to second-line injectable drugs in multidrug-resistant clinical isolates of Mycobacterium tuberculosis in France","volume":"61","author":"Brossier","year":"2017","journal-title":"Antimicrob. Agents Chemother"},{"key":"10.1016\/j.crmicr.2024.100295_bib0050","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2147\/IDR.S135935","article-title":"Rifampicin-resistant Mycobacterium tuberculosis among tuberculosis-presumptive cases at University of Gondar Hospital, northwest Ethiopia","volume":"10","author":"Jaleta","year":"2017","journal-title":"Infect. Drug Resist."},{"issue":"3","key":"10.1016\/j.crmicr.2024.100295_bib0051","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1128\/AAC.04541-14","article-title":"Phenotypic and genotypic characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates in Zhejiang, China","volume":"59","author":"Xia","year":"2015","journal-title":"Antimicrob. Agents Chemother"},{"issue":"12","key":"10.1016\/j.crmicr.2024.100295_bib0052","doi-asserted-by":"crossref","first-page":"3799","DOI":"10.1128\/AAC.47.12.3799-3805.2003","article-title":"ethA, inhA, and katG loci of ethionamide-resistant clinical Mycobacterium tuberculosis isolates","volume":"47","author":"Morlock","year":"2003","journal-title":"Antimicrob. Agents Chemother"},{"key":"10.1016\/j.crmicr.2024.100295_bib0053","series-title":"The Use of Next-Generation Sequencing For the Surveillance of Drug-Resistant tuberculosis: an Implementation Manual","year":"2023"},{"key":"10.1016\/j.crmicr.2024.100295_bib0054","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1017\/S095026882100279X","article-title":"Whole-genome sequencing of Mycobacterium tuberculosis for prediction of drug resistance","volume":"150","author":"Wang","year":"2022","journal-title":"Epidemiol. Infect."},{"key":"10.1016\/j.crmicr.2024.100295_bib0055","series-title":"Catalogue of Mutations in Mycobacterium tuberculosis Complex and Their Association With Drug Resistance","year":"2023"},{"issue":"4","key":"10.1016\/j.crmicr.2024.100295_bib0056","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1128\/mr.60.4.575-608.1996","article-title":"Proton-dependent multidrug efflux systems","volume":"60","author":"Paulsen","year":"1996","journal-title":"Microbiol. Rev."},{"issue":"5","key":"10.1016\/j.crmicr.2024.100295_bib0057","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.bbapap.2008.11.012","article-title":"Multidrug efflux transporters in the MATE family","volume":"1794","author":"Kuroda","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"issue":"7-8","key":"10.1016\/j.crmicr.2024.100295_bib0058","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1080\/00498250701883753","article-title":"Multidrug and toxic compound extrusion (MATE)-type proteins as anchor transporters for the excretion of metabolic waste products and xenobiotics","volume":"38","author":"Moriyama","year":"2008","journal-title":"Xenobiotica"},{"issue":"1","key":"10.1016\/j.crmicr.2024.100295_bib0059","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.02510-23","article-title":"Overexpression of efflux pump genes is one of the mechanisms causing drug resistance in","volume":"12","author":"Long","year":"2024","journal-title":"Microbiol. Spectr."},{"issue":"2","key":"10.1016\/j.crmicr.2024.100295_bib0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0119013","article-title":"Efflux pump gene expression in multidrug-resistant Mycobacterium tuberculosis clinical isolates","volume":"10","author":"Li","year":"2015","journal-title":"PLoS. One"},{"key":"10.1016\/j.crmicr.2024.100295_bib0061","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.tube.2017.07.012","article-title":"Single nucleotide polymorphisms in efflux pumps genes in extensively drug resistant Mycobacterium tuberculosis isolates from Pakistan","volume":"107","author":"Kanji","year":"2017","journal-title":"Tuberculosis. (Edinb)"},{"issue":"4","key":"10.1016\/j.crmicr.2024.100295_bib0062","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.diagmicrobio.2016.05.010","article-title":"Molecular analysis of genetic mutations among cross-resistant second-line injectable drugs reveals a new resistant mutation in Mycobacterium tuberculosis","volume":"85","author":"Malinga","year":"2016","journal-title":"Diagn. Microbiol. Infect. Dis."},{"issue":"2","key":"10.1016\/j.crmicr.2024.100295_bib0063","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s15010-004-3097-x","article-title":"Mycobacterium tuberculosis isolate with a distinct genomic identity overexpresses a tap-like efflux pump","volume":"32","author":"Siddiqi","year":"2004","journal-title":"Infection"},{"key":"10.1016\/j.crmicr.2024.100295_bib0064","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3389\/fmicb.2019.00216","article-title":"Mutations in efflux pump Rv1258c (Tap) cause resistance to pyrazinamide, isoniazid, and streptomycin in M","volume":"10","author":"Liu","year":"2019","journal-title":"tuberculosis. Front Microbiol."},{"issue":"1","key":"10.1016\/j.crmicr.2024.100295_bib0065","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1089\/mdr.2008.0772","article-title":"Assessment of efflux pump gene expression in a clinical isolate Mycobacterium tuberculosis by real-time reverse transcription PCR","volume":"14","author":"Jiang","year":"2008","journal-title":"Microb. Drug Resist."},{"issue":"5","key":"10.1016\/j.crmicr.2024.100295_bib0066","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1128\/AAC.06003-11","article-title":"Efflux pumps of Mycobacterium tuberculosis play a significant role in antituberculosis activity of potential drug candidates","volume":"56","author":"Balganesh","year":"2012","journal-title":"Antimicrob. Agents Chemother"},{"key":"10.1016\/j.crmicr.2024.100295_bib0067","doi-asserted-by":"crossref","first-page":"S150","DOI":"10.1016\/j.ijmyco.2016.09.067","article-title":"Increased expression of efflux pump genes in extensively drug-resistant isolates of Mycobacterium tuberculosis","volume":"5","author":"Kanji","year":"2016","journal-title":"Int. J. Mycobacteriol."},{"issue":"7","key":"10.1016\/j.crmicr.2024.100295_bib0068","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/ja.2015.9","article-title":"Study of efflux pump gene expression in rifampicin-monoresistant Mycobacterium tuberculosis clinical isolates","volume":"68","author":"Li","year":"2015","journal-title":"J. Antibiot. (Tokyo)"},{"issue":"Pt 1","key":"10.1016\/j.crmicr.2024.100295_bib0069","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1042\/bj20020615","article-title":"Overexpression and functional characterization of an ABC (ATP-binding cassette) transporter encoded by the genes drrA and drrB of Mycobacterium tuberculosis","volume":"367","author":"Choudhuri","year":"2002","journal-title":"Biochem. J."},{"key":"10.1016\/j.crmicr.2024.100295_bib0070","series-title":"WHO Treatment Guidelines For Drug-Resistant Tuberculosis 2016 Update","year":"2016"},{"key":"10.1016\/j.crmicr.2024.100295_bib0071","series-title":"Meeting report of the WHO expert consultation on the definition of extensively drug-resistant tuberculosis, 27-29 October 2020","year":"2021"},{"key":"10.1016\/j.crmicr.2024.100295_bib0072","unstructured":"WHO. WHO consolidated guidelines on tuberculosis: Module 4: treatment - drug-resistant tuberculosis treatment, 2022 update. 2022. https:\/\/www.who.int\/publications\/i\/item\/9789240063129."},{"issue":"9","key":"10.1016\/j.crmicr.2024.100295_bib0073","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1056\/NEJMoa2119430","article-title":"Bedaquiline-Pretomanid-Linezolid regimens for drug-resistant tuberculosis","volume":"387","author":"Conradie","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.crmicr.2024.100295_bib0074","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S2213-2600(23)00389-2","article-title":"Short oral regimens for pulmonary rifampicin-resistant tuberculosis (TB-PRACTECAL): An open-label, randomised, controlled, phase 2B-3, multi-arm, multicentre, non-inferiority trial","volume":"12","author":"Nyang'wa","year":"2024","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.crmicr.2024.100295_bib0075","series-title":"Rapid communication: Key Changes to the Treatment of Drug-Resistant Tuberculosis","year":"2022"},{"key":"10.1016\/j.crmicr.2024.100295_bib0076","series-title":"Key Updates to the Treatment of Drug-Resistant tuberculosis: Rapid communication, June 2024","year":"2024"},{"key":"10.1016\/j.crmicr.2024.100295_bib0077","series-title":"WHO Consolidated Guidelines On tuberculosis. Module 4: Treatment - drug-Resistant Tuberculosis treatment, 2022 Update","year":"2022"},{"key":"10.1016\/j.crmicr.2024.100295_bib0078","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/j.ijid.2020.01.042","article-title":"MDR\/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network","volume":"92","author":"Migliori","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.crmicr.2024.100295_bib0079","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1016\/j.ijid.2019.01.039","article-title":"Improving treatment outcomes for MDR-TB - Novel host-directed therapies and personalised medicine of the future","volume":"80S","author":"Rao","year":"2019","journal-title":"Int. J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.crmicr.2024.100295_bib0080","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/08830185.2021.1990277","article-title":"Host factors subverted by by Mycobacterium tuberculosis: Potential targets for host directed therapy","volume":"42","author":"Kalra","year":"2023","journal-title":"Int. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.crmicr.2024.100295_bib0081","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cell.2011.02.022","article-title":"Drug tolerance in replicating mycobacteria mediated by a macrophage-induced efflux mechanism","volume":"145","author":"Adams","year":"2011","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.crmicr.2024.100295_bib0082","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/jac\/dkv316","article-title":"Efflux pump inhibitors: targeting mycobacterial efflux systems to enhance TB therapy","volume":"71","author":"Pule","year":"2016","journal-title":"J. Antimicrob. Chemother"},{"issue":"13","key":"10.1016\/j.crmicr.2024.100295_bib0083","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.2174\/138161211795703726","article-title":"Microbial efflux pump inhibition: tactics and strategies","volume":"17","author":"Tegos","year":"2011","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.crmicr.2024.100295_bib0084","first-page":"535","article-title":"Effect of efflux pump inhibitors on drug susceptibility of ofloxacin resistant Mycobacterium tuberculosis isolates","volume":"133","author":"Singh","year":"2011","journal-title":"Indian J. Med. Res."},{"issue":"6","key":"10.1016\/j.crmicr.2024.100295_bib0085","doi-asserted-by":"crossref","first-page":"499","DOI":"10.4103\/0970-2113.217567","article-title":"Effect of efflux pump inhibitors on the susceptibility of Mycobacterium tuberculosis to isoniazid","volume":"34","author":"Jaiswal","year":"2017","journal-title":"Lung India"},{"issue":"4","key":"10.1016\/j.crmicr.2024.100295_bib0086","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.meegid.2011.08.009","article-title":"Contribution of efflux activity to isoniazid resistance in the Mycobacterium tuberculosis complex","volume":"12","author":"Rodrigues","year":"2012","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.crmicr.2024.100295_bib0087","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s12879-015-0905-0","article-title":"Tetrandrine reverses drug resistance in isoniazid and ethambutol dual drug-resistant Mycobacterium tuberculosis clinical isolates","volume":"15","author":"Zhang","year":"2015","journal-title":"BMC. Infect. Dis."},{"issue":"8","key":"10.1016\/j.crmicr.2024.100295_bib0088","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1128\/AAC.01570-07","article-title":"Identification of mutations related to streptomycin resistance in clinical isolates of Mycobacterium tuberculosis and possible involvement of efflux mechanism","volume":"52","author":"Spies","year":"2008","journal-title":"Antimicrob. Agents Chemother"},{"issue":"8","key":"10.1016\/j.crmicr.2024.100295_bib0089","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1086\/651377","article-title":"Efflux-pump-derived multiple drug resistance to ethambutol monotherapy in Mycobacterium tuberculosis and the pharmacokinetics and pharmacodynamics of ethambutol","volume":"201","author":"Srivastava","year":"2010","journal-title":"J. Infect. Dis."},{"issue":"8","key":"10.1016\/j.crmicr.2024.100295_bib0090","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00940-17","article-title":"Identification of novel efflux proteins Rv0191, Rv3756c, Rv3008, and Rv1667c involved in pyrazinamide resistance in Mycobacterium tuberculosis","volume":"61","author":"Zhang","year":"2017","journal-title":"Antimicrob. Agents Chemother"},{"issue":"6","key":"10.1016\/j.crmicr.2024.100295_bib0091","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1159\/000109769","article-title":"Importance of the efflux pump systems in the resistance of Mycobacterium tuberculosis to fluoroquinolones and linezolid","volume":"53","author":"Escribano","year":"2007","journal-title":"Chemotherapy"},{"issue":"711","key":"10.1016\/j.crmicr.2024.100295_bib0092","article-title":"Interplay between mutations and efflux in drug resistant clinical isolates of Mycobacterium tuberculosis","volume":"8","author":"Machado","year":"2017","journal-title":"Front. Microbiol."},{"issue":"1","key":"10.1016\/j.crmicr.2024.100295_bib0093","doi-asserted-by":"crossref","first-page":"e01692","DOI":"10.1128\/AAC.01692-17","article-title":"Verapamil increases the bioavailability and efficacy of bedaquiline but not clofazimine in a murine model of tuberculosis","volume":"62","author":"Xu","year":"2018","journal-title":"Antimicrob. Agents Chemother"},{"issue":"2","key":"10.1016\/j.crmicr.2024.100295_bib0094","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1002\/cpt.3108","article-title":"A dose-finding study to guide use of verapamil as an adjunctive therapy in tuberculosis","volume":"115","author":"Padmapriyadarsini","year":"2024","journal-title":"Clin. Pharmacol. Ther."},{"issue":"7","key":"10.1016\/j.crmicr.2024.100295_bib0095","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1093\/cid\/ciz1044","article-title":"Duration of exposure among close contacts of patients with infectious tuberculosis and risk of latent tuberculosis infection","volume":"71","author":"Reichler","year":"2020","journal-title":"Clin. Infect. Dis."},{"issue":"4","key":"10.1016\/j.crmicr.2024.100295_bib0096","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.ijtb.2020.07.007","article-title":"Prevalence of LTBI among household contacts of sputum positive TB patients receiving DOTS chemotherapy","volume":"67","author":"Praveen","year":"2020","journal-title":"Indian J. Tuberc."},{"issue":"1","key":"10.1016\/j.crmicr.2024.100295_bib0097","article-title":"Prevalence and predictors of tuberculosis infection among people living with HIV in a high tuberculosis burden context","volume":"10","author":"Njagi","year":"2023","journal-title":"BMJ Open. Respir. Res."},{"key":"10.1016\/j.crmicr.2024.100295_bib0098","article-title":"Risk factors of latent tuberculosis among chronic kidney disease with routine haemodialysis patients","volume":"27","author":"Bandiara","year":"2022","journal-title":"J. Clin. Tuberc. Other Mycobact. Dis."},{"issue":"1","key":"10.1016\/j.crmicr.2024.100295_bib0099","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3390\/toxics12010094","article-title":"Smoking exposure and the risk of latent tuberculosis infection: Results from NHANES 2011-2012","volume":"12","author":"Hu","year":"2024","journal-title":"Toxics."},{"key":"10.1016\/j.crmicr.2024.100295_bib0100","article-title":"The association between diabetes mellitus and the risk of latent tuberculosis infection: a systematic review and meta-analysis","volume":"9","author":"Liu","year":"2022","journal-title":"Front. Med. (Lausanne)"},{"key":"10.1016\/j.crmicr.2024.100295_bib0101","series-title":"Use of Alternative Interferon-Gamma Release Assays For the Diagnosis of TB infection: WHO Policy Statement","year":"2022"},{"issue":"2","key":"10.1016\/j.crmicr.2024.100295_bib0102","article-title":"Challenges and the way forward in diagnosis and treatment of tuberculosis infection","volume":"8","author":"Chin","year":"2023","journal-title":"Trop. Med. Infect. Dis."},{"issue":"8","key":"10.1016\/j.crmicr.2024.100295_bib0103","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S1473-3099(19)30307-X","article-title":"Global burden of latent multidrug-resistant tuberculosis: trends and estimates based on mathematical modelling","volume":"19","author":"Knight","year":"2019","journal-title":"Lancet Infect. Dis."},{"issue":"3","key":"10.1016\/j.crmicr.2024.100295_bib0104","doi-asserted-by":"crossref","first-page":"297","DOI":"10.5588\/ijtld.16.0576","article-title":"Latent tuberculous infection in household contacts of multidrug-resistant and newly diagnosed tuberculosis","volume":"21","author":"Fox","year":"2017","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"10.1016\/j.crmicr.2024.100295_bib0105","doi-asserted-by":"crossref","first-page":"l5894","DOI":"10.1136\/bmj.l5894","article-title":"Transmissibility and potential for disease progression of drug resistant","volume":"367","author":"Becerra","year":"2019","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.crmicr.2024.100295_bib0106","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1093\/cid\/ciad301","article-title":"1-year incidence of tuberculosis infection and disease among household contacts of rifampin- and multidrug-resistant tuberculosis","volume":"77","author":"Krishnan","year":"2023","journal-title":"Clin. Infect. Dis."},{"issue":"8","key":"10.1016\/j.crmicr.2024.100295_bib0107","doi-asserted-by":"crossref","first-page":"912","DOI":"10.5588\/ijtld.13.0028","article-title":"Treatment for LTBI in contacts of MDR-TB patients, Federated States of Micronesia, 2009\u20132012","volume":"18","author":"Bamrah","year":"2014","journal-title":"Int. J. Tuberc. Lung Dis."},{"issue":"2","key":"10.1016\/j.crmicr.2024.100295_bib0108","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1164\/rccm.201501-0069OC","article-title":"fluoroquinolone therapy for the prevention of multidrug-resistant tuberculosis in contacts. A cost-effectiveness analysis","volume":"192","author":"Fox","year":"2015","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"11","key":"10.1016\/j.crmicr.2024.100295_bib0109","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.5588\/ijtld.13.0872","article-title":"Children exposed to multidrug-resistant tuberculosis at a home-based day care centre: a contact investigation","volume":"18","author":"Garcia-Prats","year":"2014","journal-title":"Int. J. Tuberc. Lung Dis."},{"issue":"7","key":"10.1016\/j.crmicr.2024.100295_bib0110","doi-asserted-by":"crossref","first-page":"e1034","DOI":"10.1016\/S2214-109X(22)00113-9","article-title":"The global impact of household contact management for children on multidrug-resistant and rifampicin-resistant tuberculosis cases, deaths, and health-system costs in 2019: a modelling study","volume":"10","author":"Dodd","year":"2022","journal-title":"Lancet Glob. Health"},{"issue":"2","key":"10.1016\/j.crmicr.2024.100295_bib0111","doi-asserted-by":"crossref","first-page":"171","DOI":"10.5588\/ijtld.21.0443","article-title":"Fluoroquinolone preventive therapy for children exposed to MDR-TB","volume":"26","author":"Gureva","year":"2022","journal-title":"Int. J. Tuberc. Lung Dis."},{"issue":"3","key":"10.1016\/j.crmicr.2024.100295_bib0112","doi-asserted-by":"crossref","first-page":"ofad087","DOI":"10.1093\/ofid\/ofad087","article-title":"Tuberculosis diagnosis and preventive monotherapy among children and adolescents exposed to rifampicin-resistant tuberculosis in the household","volume":"10","author":"Apolisi","year":"2023","journal-title":"Open. Forum. Infect. Dis."},{"key":"10.1016\/j.crmicr.2024.100295_bib0113","series-title":"WHO Consolidated Guidelines On tuberculosis: Tuberculosis Preventive treatment: Module 1: prevention, Second Edition","year":"2020"},{"key":"10.1016\/j.crmicr.2024.100295_bib0114","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/mt.2015.216","article-title":"Variable virulence and efficacy of BCG vaccine strains in mice and correlation with genome polymorphisms","volume":"24","author":"Zhang","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.crmicr.2024.100295_bib0115","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/mt.2016.18","article-title":"The BCG strain pool: Diversity matters","volume":"24","author":"Bottai","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.crmicr.2024.100295_bib0116","series-title":"Use of BCG Vaccine in HIV-infected Infants","year":"2010"},{"key":"10.1016\/j.crmicr.2024.100295_bib0117","article-title":"Effects of non-tuberculous mycobacteria on BCG vaccine efficacy: A narrative review","volume":"36","author":"Ghasemi","year":"2024","journal-title":"J. Clin. Tuberc. Other Mycobact. Dis."},{"key":"10.1016\/j.crmicr.2024.100295_bib0118","doi-asserted-by":"crossref","first-page":"4842","DOI":"10.1038\/s41598-019-41008-4","article-title":"Historical BCG vaccination combined with drug treatment enhances inhibition of mycobacterial growth ex vivo in human peripheral blood cells","volume":"9","author":"Prabowo","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.crmicr.2024.100295_bib0119","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/cei.13549","article-title":"Does the BCG vaccine have different effects on strains of tuberculosis?","volume":"203","author":"Kousha","year":"2021","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.crmicr.2024.100295_bib0120","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1164\/ajrccm.153.1.8542139","article-title":"Transmission of tuberculosis to close contacts of patients with multidrug-resistant tuberculosis","volume":"153","author":"Kritski","year":"1996","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.crmicr.2024.100295_bib0121","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1016\/S1473-3099(21)00403-5","article-title":"100 years of Mycobacterium bovis bacille Calmette-Gu\u00e9rin","volume":"22","author":"Lange","year":"2022","journal-title":"Lancet Infect. Dis."},{"issue":"8","key":"10.1016\/j.crmicr.2024.100295_bib0122","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.3390\/vaccines11081304","article-title":"Next-generation TB vaccines: Progress, challenges, and prospects","volume":"11","author":"Zhuang","year":"2023","journal-title":"Vaccines. (Basel)"},{"issue":"9","key":"10.1016\/j.crmicr.2024.100295_bib0123","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1080\/21645515.2017.1335374","article-title":"Efficacy of Mycobacterium vaccae immunotherapy for patients with tuberculosis: A systematic review and meta-analysis","volume":"13","author":"Huang","year":"2017","journal-title":"Hum. Vaccin. ImmunOther"},{"issue":"3-4","key":"10.1016\/j.crmicr.2024.100295_bib0124","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.tube.2006.01.024","article-title":"RUTI: a new chance to shorten the treatment of latent tuberculosis infection","volume":"86","author":"Cardona","year":"2006","journal-title":"Tuberculosis. (Edinb)"},{"issue":"2","key":"10.1016\/j.crmicr.2024.100295_bib0125","doi-asserted-by":"crossref","first-page":"e89612","DOI":"10.1371\/journal.pone.0089612","article-title":"Safety, tolerability, and immunogenicity of the novel antituberculous vaccine RUTI: Randomized, placebo-controlled phase ii clinical trial in patients with latent tuberculosis infection","volume":"9","author":"Nell","year":"2014","journal-title":"PLoS. One"},{"key":"10.1016\/j.crmicr.2024.100295_bib0126","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3389\/fcimb.2017.00117","article-title":"Evaluation of a new IFN-\u03b3 release assay for rapid diagnosis of active tuberculosis in a high-incidence setting","volume":"7","author":"Li","year":"2017","journal-title":"Front. Cell Infect. Microbiol."},{"issue":"4","key":"10.1016\/j.crmicr.2024.100295_bib0127","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/joim.12264","article-title":"Totally drug-resistant tuberculosis and adjunct therapies","volume":"277","author":"Parida","year":"2015","journal-title":"J. Intern. Med."},{"issue":"50","key":"10.1016\/j.crmicr.2024.100295_bib0128","doi-asserted-by":"crossref","first-page":"7277","DOI":"10.1016\/j.vaccine.2021.06.049","article-title":"MTBVAC, a live TB vaccine poised to initiate efficacy trials 100 years after BCG","volume":"39","author":"Mart\u00edn","year":"2021","journal-title":"Vaccine"}],"container-title":["Current Research in Microbial Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666517424000786?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666517424000786?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T05:23:30Z","timestamp":1733203410000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666517424000786"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":128,"alternative-id":["S2666517424000786"],"URL":"https:\/\/doi.org\/10.1016\/j.crmicr.2024.100295","relation":{},"ISSN":["2666-5174"],"issn-type":[{"value":"2666-5174","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impacts of MDR\/XDR-TB on the global tuberculosis epidemic: Challenges and opportunities","name":"articletitle","label":"Article Title"},{"value":"Current Research in Microbial Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.crmicr.2024.100295","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100295"}}